Back

FALCON: Closed-Loop Multi-Objective Optimization of Lipid Nanoparticles for Cell-Selective mRNA Delivery

Toh, W. H.; Cheng, L.; Chang, B.; Yu, D.; Ma, J.; Huang, X.; Weng, G.; Zhu, Y.; Lu, X.; Lin, J.; Liu, J.; Choy, J.; Greco, A.; Jain, M.; Yang, J.; Patel, M.; Shoemaker, G.; Cozzone, I.; Antov, D.; Zhang, K.; Kayabas, S.; Shin, C.; Aggarwal, A.; Green, J.; Tzeng, S.; Kumar, R.; Konig, M. F.; Mao, H.-Q.

2026-06-17 bioengineering
10.64898/2026.06.13.731774 bioRxiv
Show abstract

Efficient, cell type-selective delivery of genetic payloads remains a central challenge in the development of gene and cell therapies. Lipid nanoparticles (LNPs) offer a versatile delivery platform, but their optimization is hindered by reliance on brute-force screening methods that are laborious, resource-intensive, and focus on single targets. Here, we present FALCON (Framework for Active Learning-driven Compositional Optimization of Nanoparticles), a closed-loop pipeline that leverages iterative screening, surrogate modeling, and multi-objective optimization to accelerate LNP compositional design. In B cell-targeted validation experiments, FALCON-optimized LNPs achieved a 1.8-fold increase in splenic B cell transfection in vivo compared with reference compositions. When optimized for selectivity, FALCON LNPs displayed an 84-fold improvement in selective transfection of splenic B cells over off-target liver populations and enabled spleen-tropic behavior across factorial panels of varying ionizable and helper lipid chemistries. In vaccine studies, these LNPs induced higher IgG2c antibody titers and a more Th1-biased immune profile. FALCON was also deployed to optimize LNPs for myeloid cell-selective delivery, achieving enhanced in vivo selectivity following systemic administration both across and within spleen and liver compartments. Our results establish FALCON as a useful tool for data-driven design of LNP compositions for precision gene delivery.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of Controlled Release
44 papers in training set
Top 0.1%
18.6%
2
Advanced Science
286 papers in training set
Top 0.5%
7.9%
3
Advanced Healthcare Materials
85 papers in training set
Top 0.3%
7.3%
4
Nature Communications
5641 papers in training set
Top 23%
6.8%
5
ACS Nano
113 papers in training set
Top 0.6%
3.5%
6
Advanced Functional Materials
46 papers in training set
Top 0.4%
3.2%
7
Small
78 papers in training set
Top 0.5%
3.1%
50% of probability mass above
8
Nature Biotechnology
172 papers in training set
Top 2%
2.7%
9
Biomaterials
84 papers in training set
Top 0.7%
2.4%
10
Science Advances
1243 papers in training set
Top 18%
1.9%
11
ACS Central Science
71 papers in training set
Top 0.7%
1.7%
12
Bioengineering & Translational Medicine
21 papers in training set
Top 0.2%
1.7%
13
Trends in Biotechnology
12 papers in training set
Top 0.1%
1.7%
14
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.5%
1.7%
15
Nature Biomedical Engineering
47 papers in training set
Top 0.7%
1.7%
16
Nano Letters
71 papers in training set
Top 0.8%
1.5%
17
Advanced Materials
56 papers in training set
Top 0.7%
1.3%
18
Angewandte Chemie International Edition
93 papers in training set
Top 1%
1.3%
19
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 34%
1.1%
20
Scientific Reports
3612 papers in training set
Top 64%
1.1%
21
Biomacromolecules
29 papers in training set
Top 0.4%
1.1%
22
ACS Chemical Biology
167 papers in training set
Top 2%
1.0%
23
ACS Synthetic Biology
287 papers in training set
Top 2%
1.0%
24
Advanced Therapeutics
17 papers in training set
Top 0.3%
1.0%
25
Communications Medicine
113 papers in training set
Top 4%
1.0%
26
Communications Chemistry
48 papers in training set
Top 1%
1.0%
27
Nature Chemistry
42 papers in training set
Top 0.9%
0.8%
28
Molecular Pharmaceutics
16 papers in training set
Top 0.4%
0.8%
29
Nature Materials
28 papers in training set
Top 0.7%
0.6%
30
Cell Reports Methods
165 papers in training set
Top 4%
0.6%